ERBB2 and breast cancer: Recent studies have revealed that intrinsic subtypes of breast cancers characterized by ER-negative, PgR-negative, and HER2-negative expression (i.e., triple-negative breast cancer [TNBC]), or by ER-negative, PgR-negative, and HER2-positive expression have a poor prognosis [22–24].